These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16079637)

  • 21. Statins and mortality.
    Muntwyler J; Gutzwiller F
    Eur Heart J; 2002 Feb; 23(3):183-4. PubMed ID: 11792128
    [No Abstract]   [Full Text] [Related]  

  • 22. Vascular insulin response is preserved in non-diabetic patients with coronary artery disease, despite endothelial dysfunction.
    Ihlemann N; Rask-Madsen C; Køber L; Torp-Pedersen C
    Scand Cardiovasc J; 2004 Mar; 38(1):22-7. PubMed ID: 15204243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
    van der Harst P; Wagenaar LJ; Buikema H; Voors AA; Plokker HW; Morshuis WJ; Six AJ; Boonstra PW; Nickenig G; Wassmann S; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2005 Nov; 96(10):1361-4. PubMed ID: 16275178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pravastatin improves postprandial endothelial dysfunction and hemorheological deterioration in patients with effort angina pectoris.
    Umemoto T; Yasu T; Arao K; Ikeda N; Horie Y; Sugimura H; Kawakami M; Fujita H; Momomura SI
    Heart Vessels; 2017 Sep; 32(9):1051-1061. PubMed ID: 28396938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxy-methylglutaryl-coenzyme A reductase inhibition improves endothelial dysfunction in type-1 diabetes.
    Joyce M; Moore K; Thompson C; Fitzgerald P; Fennessy F; Kelly CJ; Bouchier-Hayes DJ
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):432-7. PubMed ID: 15015196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ; Chew GT; Davis TM; Watts GF
    Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens.
    Bulut D; Hanefeld C; Bulut-Streich N; Graf C; Mügge A; Spiecker M
    Cardiology; 2005; 104(4):176-80. PubMed ID: 16155389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerivastatin and endothelial function in elderly patients with diabetes mellitus.
    Stein JH; Carlsson CM
    Circulation; 2002 Jan; 105(4):E32-3. PubMed ID: 11815445
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
    Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M
    Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial.
    Mulder HJ; van Geel PP; Schalij MJ; van Gilst WH; Zwinderman AH; Bruschke AV;
    Heart; 2003 May; 89(5):557-8. PubMed ID: 12695469
    [No Abstract]   [Full Text] [Related]  

  • 32. New insights into the relationship between myocardial perfusion and lipid-lowering.
    Blumenthal RS; Gluckman TJ
    J Am Coll Cardiol; 2003 Aug; 42(4):611-3. PubMed ID: 12932589
    [No Abstract]   [Full Text] [Related]  

  • 33. Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic responses induced by bradykinin.
    Tarutani Y; Matsumoto T; Takashima H; Yamane T; Horie M
    Hypertens Res; 2005 Jan; 28(1):59-66. PubMed ID: 15969256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet and exercise: are they worth it in the era of advanced pharmacotherapy?
    Kuvin JT
    J Cardiopulm Rehabil; 2006; 26(5):294-6. PubMed ID: 17003594
    [No Abstract]   [Full Text] [Related]  

  • 35. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
    Corte TJ; Wort SJ
    Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
    Hashimoto M; Akita H
    Circulation; 2002 Jan; 105(4):E30-1. PubMed ID: 11815444
    [No Abstract]   [Full Text] [Related]  

  • 40. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.